Sangamo Therapeutics: A Bust Or Billion Dollar Valuation In The Remaking

SGMO 12 month stock chart on 07/22/24 (Seeking Alpha) Discussion on Financials Isa-vec is a GTx designed to carry the DNA for human alpha-Gal A to the liver of Fabry patients by a single IV infusion so that the liver can start producing functional alpha-Gal-A. The ph1/2 STAAR clinical trial (NCT04046224) dosed 24 patients who were either on ERT, been off it for 6 months or more, or were ERT-naïve. Dr. Robert Hopkin of Cincinnati Children's Hospital Medical Center was one of the investigators in the trial an ...